-
Mashup Score: 14JennyCo Alliance with Ethical Victoria.Ai for Mobile Application - 23 day(s) ago
JennyCo, Inc., a first-of-its-kind proprietary healthcare data exchange powered by decentralized Web3 and AI, has announced an alliance and exclusive
Source: www.businesswire.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 12PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round - 1 month(s) ago
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8CALQUENCEĀ® (acalabrutinib) granted Priority Review in the US for patients with untreated mantle cell lymphoma - 1 month(s) ago
AstraZenecaās supplemental New Drug Application (sNDA) for CALQUENCEĀ® (acalabrutinib) has been accepted and granted Priority Review in the US for the
Source: www.businesswire.comCategories: General Medicine News, Oncologists1Tweet-
šØ NEWS šØ Acalabrutinib, a BTK inhibitor, has received priority review for a sNDA in the US for the treatment of adult patients with untreated MCL. The decision was supported by results from the phase III ECHO trial. Read more š https://t.co/MdGCaXqfMA #lymsm #lymphoma #MedNews https://t.co/b8SN1C7EYt
-
-
Mashup Score: 0GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe - 1 month(s) ago
GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranosti
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States - 1 month(s) ago
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 46Pfizerās TALZENNAĀ® in Combination with XTANDIĀ® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial - 1 month(s) ago
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of
Source: www.businesswire.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 46Pfizerās TALZENNAĀ® in Combination with XTANDIĀ® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial - 1 month(s) ago
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of
Source: www.businesswire.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0INBRAIN Neuroelectronics Announces Worldās First Human Graphene-Based Brain Computer Interface Procedure - 2 month(s) ago
INBRAIN Neuroelectronics Announces Worldās First Human Graphene-Based Brain Computer Interface Procedure
Source: www.businesswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Rune Labsā StrivePD Nearly Halves ER Visits for Parkinsonās Patients in Program with Kaiser Permanente - 2 month(s) ago
Rune Labs, a leader in precision medicine for Parkinsonās Disease (PD), today previewed the results of an ongoing nine-month research program involvin
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 161
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceut
Source: www.businesswire.comCategories: General Medicine News, Infectious DiseaseTweet
JennyCo is at the intersection of Healthcare and IoT Data, AI, and Blockchain, and we are delighted to work with Victoria and Sharik to provide a compelling consumer app and wellness service in the next few months. https://t.co/mORTWKsVe9